Synta Announces FDA's Oncologic Drugs Advisory Committee to Discuss Pediatric Uses for Ganetespib
November 05, 2014 at 08:02 AM EST
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company has been invited by the U.S. Food and Drug Administration ...